THE EFFECT OF TOPICAL FLUTICASONE PROPIONATE ON INTRANASAL HISTAMINE CHALLENGE IN SUBJECTS WITH PERENNIAL ALLERGIC RHINITIS

被引：12

作者：

BIRCHALL, MA

HENDERSON, JC

STUDHAM, JM

PHILLIPS, I

PRIDE, NB

FULLER, RW

机构：

[1] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT CLIN PHARMACOL, LONDON W12 0HS, ENGLAND

[2] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT MED, DIV RESP, LONDON W12 0HS, ENGLAND

[3] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT CYTOPATHOL, LONDON W12 0HS, ENGLAND

来源：

CLINICAL OTOLARYNGOLOGY | 1995年 / 20卷 / 03期

关键词：

STEROID; NASAL; VESSELS; CYTOLOGY; ESIONOPHIL; SECRETION; LYSOZYME; FLUTICASONE; HISTAMINE;

D O I：

10.1111/j.1365-2273.1995.tb01848.x

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

The mechanism of action of topical intranasal steroids is obscure. To investigate this, we have studied the effects of a topical intranasal corticosteroid, fluticasone propionate on nasal airflow resistance (Rnaw), secretions, cytological smears and symptoms. Fluticasone propionate aqueous nasal spray was given to 11 patients with perennial allergic rhinitis in a double-blind, placebo-controlled study. On each day, patients were challenged with ascending doses of histamine. Rnaw, secretion volume, total protein, mucin, lysozyme and albumin were measured. Nasal smears were taken and sneezes counted. Diary card data were collected for both treatment periods. There was a significant, dose-related increase in Rnaw and sneezing on histamine challenge. A single dose of fluticasone had no effect on any parameter. After 4 weeks of treatment, resistance measurements were reduced (post-challenge g.m.2.8 cmH(2)O/l/s, Q1-Q3 1.6-4.8; placebo 4.2, 2.9-5.3: P < 0.0001) as were baseline secretion volumes (mean 2.4 ml/5 min, c.i. 4.0-15.7; placebo 3.3, 2.8-3.8: P < 0.05). Eosinophil counts were suppressed (fluticasone 5.8%, c.i. 4.0-15.7; placebo 23.3%, 12.4-34.1: P < 0.05) and the composite symptom score reduced (P < 0.05). Fluticasone has long-term effects on the nasal response to histamine in perennial allergic rhinitis and part of this effect is likely to be vascular.

引用

页码：204 / 210

页数：7

共 23 条

[1]

Turkeltaub P.C., Gergen P.J., Prevalence of upper and lower respiratory conditions in the US population by social and environmental factors: data from the second National Health and Nutrition Examination Survey, 1976 to 1980 (NHANES II), J. Allergy Clin. Immunol., 67, pp. 147-156, (1981)

[2]

Pipkorn U., Budesonide and nasal histamine challenge, Allergy, 37, pp. 359-363, (1982)

[3]

Orgel H.A., Meltzer E.O., Kemp J.P., Welch M.J., Clinical, rhinomanometric and cytologic evaluation of seasonal allergic rhinitis treated with beclomethasone dipropionate nasal spray as aqueous spray or pressurised aerosol, J. Allergy Clin. Immunol., 77, pp. 858-864, (1986)

[4]

Bende M., Irlander K., Fluticasone propionate aqueous nasal spray: a placebo‐controlled trial in birch pollen rhinitis, (1990)

[5]

Bascom R., Wachs M., Naclerio R.M., Pipkorn U., Galli S., Lichenstein I.M., Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment, J. Allergy Clin. Immunol., 81, pp. 580-589, (1991)

[6]

Cockcroft D.W., Killian D.N., Mellon J.J.A., Hargreave F.E., Bronchial reactivity to inhaled histamine: a method and clinical survey, Clin. Allergy, 7, pp. 235-243, (1977)

[7]

Druce H.M., Schumacher M.J., Nasal provocation challenge: report of the committee on upper airway allergy, J. Allergy Clin. Immunol., 86, pp. 261-264, (1990)

[8]

Naclerio R.M., Togias A.G., The nasal allergic reaction: observations on the role of histamine, Clin. Exp. Allergy, 21, pp. 13-19, (1991)

[9]

Corrado O.J., Gould C.A.L., Kassab J.Y., Da vies R.J., Nasal response of rhinitic and non‐rhinitic subjects to histamine and methacholine: a comparative study, Thorax, 41, pp. 863-868, (1986)

[10]

Phillipps G.H., Structure‐activity relationships of topically active steroids: the selection of fluticasone propionate, Resp. Med., 84, pp. 19-23, (1990)

← 1 2 3 →